Rinotec 40 mg Injection
  1. Home
  2. Pharma Products
  3. United Biotech Pvt Ltd
  4. Rinotec 40 mg Injection

Rinotec 40 mg Injection

Rinotec 40 mg Injection contains irinotecan 40 mg, a topoisomerase I inhibitor used as an anticancer medicine. It is primarily used in the treatment of advanced or metastatic colorectal cancer. The injection is administered intravenously by a qualified healthcare professional.

BUY NOW

Category

Rinotec 40 mg Injection works by inhibiting topoisomerase I, an enzyme involved in cancer-cell DNA replication. Irinotecan may be used alone or as part of combination chemotherapy regimens according to the patient’s diagnosis and treatment protocol. The dose and treatment schedule are determined by the treating oncologist based on the patient’s condition and response to therapy. Regular monitoring may be required because treatment can cause diarrhea, nausea, vomiting, and reduced blood-cell counts.

Technical Specification

Specification Details
Active Ingredient Irinotecan
Strength 40 mg
Dosage Form Injection
Route of Administration Intravenous
Pack Size 1 Vial
Manufacturer United Biotech Pvt Ltd

Product Also Known As

Rinotec 40 mg Injection, Rinotec 40 mg Infusion, Irinotecan 40 mg Injection, Irinotecan Hydrochloride 40 mg Injection, Irinotecan 40 mg Infusion, Irinotecan Anticancer Injection, Topoisomerase I Inhibitor Injection